Conn K, Wasson P, McFarlane S, Tong L, Brown J, Grant K, et al. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response. J Virol. 2016;90:4807-4826 pubmed publisher

Argenta D, Silva I, Bassani V, Koester L, Teixeira H, Simões C. Antiherpes evaluation of soybean isoflavonoids. Arch Virol. 2015;160:2335-42 pubmed publisher

Fields S, Bhatia G, Fong J, Liu M, Shankar G. SR-2P vaginal microbicide gel provides protection against herpes simplex virus 2 when administered as a combined prophylactic and postexposure therapeutic. Antimicrob Agents Chemother. 2015;59:5697-704 pubmed publisher

Gordts S, Férir G, D huys T, Petrova M, Lebeer S, Snoeck R, et al. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications. PLoS ONE. 2015;10:e0131219 pubmed publisher

Wang P, Zhang Q, Yao Y, Giese R. Cationic Xylene Tag for Increasing Sensitivity in Mass Spectrometry. J Am Soc Mass Spectrom. 2015;26:1713-21 pubmed publisher

Hafidh R, Abdulamir A, Abu Bakar F, Sekawi Z, Jahansheri F, Jalilian F. Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines. BMC Complement Altern Med. 2015;15:179 pubmed publisher

Astani A, Albrecht U, Schnitzler P. Piroxicam inhibits herpes simplex virus type 1 infection in vitro. Pharmazie. 2015;70:331-6 pubmed

Kottaridis P, North J, Tsirogianni M, Marden C, Samuel E, Jide Banwo S, et al. Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial. PLoS ONE. 2015;10:e0123416 pubmed publisher

Cirri M, Maestrelli F, Mennini N, Mura P. Combined use of bile acids and aminoacids to improve permeation properties of acyclovir. Int J Pharm. 2015;490:351-9 pubmed publisher

Metushi I, Wriston A, Banerjee P, Gohlke B, English A, Lucas A, et al. Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity. PLoS ONE. 2015;10:e0124878 pubmed publisher

Liu Y, Li S. A Cell Culture Model of Latent and Lytic Herpes Simplex Virus Type 1 Infection in Spiral Ganglion. ORL J Otorhinolaryngol Relat Spec. 2015;77:141-9 pubmed publisher

Pérez Toro I, Domínguez Martín A, Choquesillo Lazarte D, Vílchez Rodríguez E, González Pérez J, Castiñeiras A, et al. Lights and shadows in the challenge of binding acyclovir, a synthetic purine-like nucleoside with antiviral activity, at an apical-distal coordination site in copper(II)-polyamine chelates. J Inorg Biochem. 2015;148:84-92 pubmed publisher

Komazin Meredith G, Cardinale S, Comeau K, Magalhaes K, Hartline C, Williams J, et al. TAOK3 phosphorylates the methylenecyclopropane nucleoside MBX 2168 to its monophosphate. Antiviral Res. 2015;119:23-7 pubmed publisher

Naderkhani E, Vasskog T, Flaten G. Biomimetic PVPA in vitro model for estimation of the intestinal drug permeability using fasted and fed state simulated intestinal fluids. Eur J Pharm Sci. 2015;73:64-71 pubmed publisher

Bello M, Junior A, Vieira B, Dias L, de Sousa V, Castro H, et al. Sodium montmorillonite/amine-containing drugs complexes: new insights on intercalated drugs arrangement into layered carrier material. PLoS ONE. 2015;10:e0121110 pubmed publisher

Cagno V, Donalisio M, Civra A, Cagliero C, Rubiolo P, Lembo D. In vitro evaluation of the antiviral properties of Shilajit and investigation of its mechanisms of action. J Ethnopharmacol. 2015;166:129-34 pubmed publisher

Ramasubramanyan S, Osborn K, Al Mohammad R, Naranjo Perez Fernandez I, Zuo J, Balan N, et al. Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression. Nucleic Acids Res. 2015;43:3563-77 pubmed publisher

Matson K, Shaffer C, Beck G, Simonsen K. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Pharmacotherapy. 2015;35:337-43 pubmed publisher

Billat P, Sauvage F, Picard N, Tafzi N, Alain S, Essig M, et al. Liquid chromatography tandem mass spectrometry quantitation of intracellular concentrations of ganciclovir and its phosphorylated forms. Anal Bioanal Chem. 2015;407:3449-56 pubmed publisher

Engesland A, Skalko Basnet N, Flaten G. Phospholipid vesicle-based permeation assay and EpiSkin® in assessment of drug therapies destined for skin administration. J Pharm Sci. 2015;104:1119-27 pubmed publisher

Coleman C, WOHLFORD E, Smith N, King C, Ritchie J, Baresel P, et al. Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. J Virol. 2015;89:2301-12 pubmed publisher

Al Hussaini A, Latif F, Berry S. Ear pain, vesicular rash, and facial palsy. BMJ. 2014;349:g7572 pubmed publisher

Hill J, Quenelle D, Cardin R, Vogel J, Clement C, Bravo F, et al. Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes. Sci Transl Med. 2014;6:265ra169 pubmed publisher

Jhun P, Bright A, Herbert M. Don't let herpes melt your brain!. Ann Emerg Med. 2014;64:589-90 pubmed publisher

Dias F, Marçal F, Oliveira J, Póvoas M, Mouzinho A, Marques J. Exuberant varicella-zoster exanthema and pneumonia as clinical clue for HIV infection. J Pediatr. 2015;166:199 pubmed publisher

Alebouyeh M, Amini H. Rapid determination of lamivudine in human plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;975:40-4 pubmed publisher

Rowland A, Mackenzie P, Miners J. Transporter-mediated uptake of UDP-glucuronic acid by human liver microsomes: assay conditions, kinetics, and inhibition. Drug Metab Dispos. 2015;43:147-53 pubmed publisher

Bokhart M, Rosen E, Thompson C, Sykes C, Kashuba A, Muddiman D. Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization. Anal Bioanal Chem. 2015;407:2073-84 pubmed publisher

Yuminoki K, Seko F, Horii S, Takeuchi H, Teramoto K, Nakada Y, et al. Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat. J Pharm Sci. 2014;103:3772-3781 pubmed publisher

Ito N, Ito K, Ikebuchi Y, Kito T, Miyata H, Toyoda Y, et al. Organic cation transporter/solute carrier family 22a is involved in drug transfer into milk in mice. J Pharm Sci. 2014;103:3342-8 pubmed publisher

Heidary Navid M, Laszczyk Lauer M, Reichling J, Schnitzler P. Pentacyclic triterpenes in birch bark extract inhibit early step of herpes simplex virus type 1 replication. Phytomedicine. 2014;21:1273-80 pubmed publisher

Burton M, Penman A, Sunesara I, McGuire B, Hook E. A pilot study examining the safety and tolerability of valacyclovir in veterans with hepatitis C virus/herpes simplex virus type 2 coinfection. Am J Med Sci. 2014;348:455-9 pubmed publisher

Shankar G, Alt C. Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection. J Antimicrob Chemother. 2014;69:3282-93 pubmed publisher

Krishnaiah Y, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, et al. Development of performance matrix for generic product equivalence of acyclovir topical creams. Int J Pharm. 2014;475:110-22 pubmed publisher

Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun Vignes B, Ravaud P, et al. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev. 2014;:CD009036 pubmed publisher

Sauter M, Gauger J, Brandt C. Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps. Antiviral Res. 2014;109:83-96 pubmed publisher

Rice C, Yadav S, Boyanton B, Subedi P, Band J. Clinical problem-solving. A creeping suspicion. N Engl J Med. 2014;371:68-73 pubmed publisher

Mateos Martín M, Fuguet E, Jiménez Ardón A, Herrero Uribe L, Tamayo Castillo G, Torres J. Identification of polyphenols from antiviral Chamaecrista nictitans extract using high-resolution LC-ESI-MS/MS. Anal Bioanal Chem. 2014;406:5501-6 pubmed publisher

Sahni N, Mandal A, Maheshwari N. Secondary viral encephalitis in a patient with pyogenic liver abscess. Anaesth Intensive Care. 2014;42:528-30 pubmed

Roizenblatt S, Rosa N. Images in clinical medicine. Herpes zoster involving the S1 dermatome. N Engl J Med. 2014;370:2031 pubmed publisher

Morales Indiano C, Arenillas Rocha L, Mas Bosch V, Florensa Brichs L. Howell-Jolly body-like inclusions in immunocompromised patients with antiviral treatment. Ann Hematol. 2014;93:2091-2 pubmed publisher

Nallagundla S, Patnala S, Kanfer I. Comparison of in vitro release rates of acyclovir from cream formulations using vertical diffusion cells. AAPS PharmSciTech. 2014;15:994-9 pubmed publisher

Schubert A, Gentner E, Bohn K, Schwarz M, Mertens T, Sauerbrei A. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes. Antiviral Res. 2014;107:16-22 pubmed publisher

Schaal S, Kagan A, Wang Y, Chan C, Kaplan H. Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation. JAMA Ophthalmol. 2014;132:881-2 pubmed publisher

Gould D. Varicella zoster virus: chickenpox and shingles. Nurs Stand. 2014;28:52-8; quiz 60 pubmed publisher

Civitelli L, Panella S, Marcocci M, De Petris A, Garzoli S, Pepi F, et al. In vitro inhibition of herpes simplex virus type 1 replication by Mentha suaveolens essential oil and its main component piperitenone oxide. Phytomedicine. 2014;21:857-65 pubmed publisher

Villa D, Skinnider B. Herpes simplex virus lymphadenitis. Blood. 2014;123:12 pubmed

Pinto A, Leite J, Neves A, da Silva G, Vargas M, Paixão I. Synthetic aminomethylnaphthoquinones inhibit the in vitro replication of bovine herpesvirus 5. Arch Virol. 2014;159:1827-33 pubmed publisher

Naderkhani E, Erber A, Skalko Basnet N, Flaten G. Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay. J Pharm Sci. 2014;103:661-8 pubmed publisher

Boundy K, Fraire A, Oliveira P. A patient with progressive dyspnea and multiple foci of airspace consolidation. Chest. 2014;145:167-172 pubmed publisher

Oh I, Yeo S. The reply. Am J Med. 2013;126:e33 pubmed publisher

Turgeon R, Allan G. Uncertainties around antivirals in severe Bell's palsy trial. Am J Med. 2013;126:e31 pubmed publisher

Lee H, Yeo S. The reply. Am J Med. 2013;126:e29 pubmed publisher

de Ru J, van der Veen E. Combination therapy for Bell's palsy. Am J Med. 2013;126:e27 pubmed publisher

Bader M. Herpes zoster: diagnostic, therapeutic, and preventive approaches. Postgrad Med. 2013;125:78-91 pubmed publisher

Chen Y, Huang K, Peng C. A man with diffuse vesicular rash and epigastric pain. Gastroenterology. 2013;145:e9-10 pubmed publisher

Ladizinski B, Rukhman E, Lee K. A 4-day-old neonate with a widespread vesicular rash. JAMA. 2013;310:971-2 pubmed publisher

Park P, Antoine T, Farooq A, Valyi Nagy T, Shukla D. An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection. Invest Ophthalmol Vis Sci. 2013;54:6373-81 pubmed publisher

Pan D, Kaye S, Hopkins M, Kirwan R, Hart I, Coen D. Common and new acyclovir resistant herpes simplex virus-1 mutants causing bilateral recurrent herpetic keratitis in an immunocompetent patient. J Infect Dis. 2014;209:345-9 pubmed publisher

Mujugira A, Magaret A, Celum C, Baeten J, Lingappa J, Morrow R, et al. Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial. J Infect Dis. 2013;208:1366-74 pubmed publisher

van Velzen M, van de Vijver D, van Loenen F, Osterhaus A, Remeijer L, Verjans G. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. J Infect Dis. 2013;208:1359-65 pubmed publisher

James S, Prichard M. A possible pitfall in acyclovir prophylaxis for recurrent herpetic keratitis?. J Infect Dis. 2013;208:1353-5 pubmed publisher

Jongsma H, Bouts A, Cornelissen E, Beersma M, Cransberg K. Cytomegalovirus prophylaxis in pediatric kidney transplantation: the Dutch experience. Pediatr Transplant. 2013;17:510-7 pubmed publisher

Eljamel S. Response. J Neurosurg. 2013;118:1386 pubmed

Svirskis D, Seyfoddin A, Chalabi S, In Kim J, Langford C, Painter S, et al. Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties. Pharm Dev Technol. 2014;19:571-6 pubmed publisher

Nalcacioglu Yuksekkaya P, Ozdal P, Teke M, Kara C, Ozturk F. Presumed herpetic anterior uveitis: a study with retrospective analysis of 79 cases. Eur J Ophthalmol. 2014;24:14-20 pubmed publisher

Tobian A, Grabowski M, Serwadda D, Newell K, Ssebbowa P, Franco V, et al. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy. J Infect Dis. 2013;208:839-46 pubmed publisher

Yao J, Zhang Y, Ramishetti S, Wang Y, Huang L. Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate. J Control Release. 2013;170:414-20 pubmed publisher

Andronova V, Grokhovskii S, Surovaia A, Gurskii G, Deriabin P, L vov D, et al. [Estimation of activity of bis-netropsin derivatives based on a model of an experimental cutaneous herpes simplex virus disease of guinea pigs]. Vopr Virusol. 2013;58:32-5 pubmed

Huang S, Murai J, Dalla Rosa I, Dexheimer T, Naumova A, Gmeiner W, et al. TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res. 2013;41:7793-803 pubmed publisher

Gueudry J, Boutolleau D, Gueudin M, Burrel S, Miri A, Bodaghi B, et al. Acyclovir-resistant varicella-zoster virus keratitis in an immunocompetent patient. J Clin Virol. 2013;58:318-20 pubmed publisher

Burrel S, Boutolleau D, Azar G, Doan S, Deback C, Cochereau I, et al. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis. J Clin Virol. 2013;58:321-4 pubmed publisher

Stoopler E, Balasubramaniam R. Topical and systemic therapies for oral and perioral herpes simplex virus infections. J Calif Dent Assoc. 2013;41:259-62 pubmed

Silva G, Caldeira A, Damico F, Takahashi B, Silva Cunha A, Fialho S. Analysis of acyclovir in vitreous humor by a validated HPLC method. Pharmazie. 2013;68:235-9 pubmed

Pride H, Tollefson M, Silverman R. What's new in pediatric dermatology?: part II. Treatment. J Am Acad Dermatol. 2013;68:899.e1-11; quiz 910-2 pubmed publisher

Revere K, Davidson S. Update on management of herpes keratitis in children. Curr Opin Ophthalmol. 2013;24:343-7 pubmed publisher

Xiong T, Li Y, Li Z, Xie X, Lu L. Real-time dynamic optical imaging of ACC-M tumor cells killed by HSV-tk/ACV system. J Nanosci Nanotechnol. 2013;13:123-8 pubmed

Caraballo R, Reyes G, Avaria M, Buompadre M, Gonzalez M, Fortini S, et al. Febrile infection-related epilepsy syndrome: a study of 12 patients. Seizure. 2013;22:553-9 pubmed publisher

Linthavong O, Franasiak J, Ivester T. Febrile illness in pregnancy: disseminated herpes simplex virus. Obstet Gynecol. 2013;121:675-81 pubmed publisher

Navarro R, Kala L, Freeman W, Hanel R, Tawk R. Letter to the editor: Herpes encephalitis. J Neurosurg. 2013;118:1385-6 pubmed publisher

. Varicella death of an unvaccinated, previously healthy adolescent--Ohio, 2009. MMWR Morb Mortal Wkly Rep. 2013;62:261-3 pubmed

Krawczyk A, Arndt M, Grosse Hovest L, Weichert W, Giebel B, Dittmer U, et al. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc Natl Acad Sci U S A. 2013;110:6760-5 pubmed publisher

Perti T, Saracino M, Baeten J, Johnston C, Diem K, Ocbamichael N, et al. High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial. J Acquir Immune Defic Syndr. 2013;63:201-8 pubmed publisher

Wasserman M, Rose A. An unusual presenting complaint for herpes zoster. Am J Med. 2013;126:e3-4 pubmed publisher

Ferrari G, Iuliano L, Viganò M, Rama P. Impending corneal perforation after collagen cross-linking for herpetic keratitis. J Cataract Refract Surg. 2013;39:638-41 pubmed publisher

Treesirichod A, Chaiyakulsil C, Prommalikit O, Assadamongkol K. Acne-like presentation of recurrent varicella infection in a child with nephrotic syndrome. J Med Assoc Thai. 2012;95 Suppl 12:S134-7 pubmed

Watson D. Should all adults with varicella be prescribed antiviral treatment?. Med J Aust. 2013;198:259 pubmed

Wu S, Tan L, Wang G, Peng G, Kang C, Tang Y. Binding characteristics of homogeneous molecularly imprinted polymers for acyclovir using an (acceptor-donor-donor)-(donor-acceptor-acceptor) hydrogen-bond strategy, and analytical applications for serum samples. J Chromatogr A. 2013;1285:124-31 pubmed publisher

Pinninti S, Kimberlin D. Neonatal herpes simplex virus infections. Pediatr Clin North Am. 2013;60:351-65 pubmed publisher

Hamoudi H, Holm L. [Epithelial herpes simplex virus keratitis]. Ugeskr Laeger. 2013;175:744 pubmed

Takaoka Y, Miyachi Y, Yoshikawa Y, Tanioka M, Fujisawa A, Endo Y. Bilateral disseminated herpes zoster in an immunocompetent host. Dermatol Online J. 2013;19:13 pubmed

Kodama Y, Okamoto Y, Nishi J, Hashiguchi S, Yamaki Y, Kurauchi K, et al. Ramsay Hunt syndrome in a girl with acute lymphoblastic leukemia during maintenance therapy. J Pediatr Hematol Oncol. 2013;35:e224-5 pubmed publisher

Salem A, Abdou I, Saleh H. Application of quantitative nuclear magnetic resonance spectroscopy for the determination ofamantadine and acyclovir in plasma and pharmaceutical samples. J AOAC Int. 2012;95:1644-51 pubmed

Owers D, Webster A, Strippoli G, Kable K, Hodson E. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2013;:CD005133 pubmed publisher

Hodson E, Ladhani M, Webster A, Strippoli G, Craig J. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2013;:CD003774 pubmed publisher

Dupin N. [Treatment of major sexually transmitted infections]. Presse Med. 2013;42:459-60 pubmed publisher

Andersen L, Christensen A, Thelle T. [Ramsay Hunt syndrome in a 13-year-old boy]. Ugeskr Laeger. 2013;175:507-8 pubmed

Hashemi N, Zhang J, Volpi J, Lee A, Gordon L. A pox upon your house. Surv Ophthalmol. 2013;58:640-3 pubmed publisher

. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid. Prescrire Int. 2011;20:205-7 pubmed

Haik J, Weissman O, Stavrou D, Ben Noon H, Liran A, Tessone A, et al. Is prophylactic acyclovir treatment warranted for prevention of herpes simplex virus infections in facial burns? A review of the literature. J Burn Care Res. 2011;32:358-62 pubmed publisher

Perkins N, Nisbet M, Thomas M. Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review. Sex Transm Infect. 2011;87:292-5 pubmed publisher

Prelog M, Schönlaub J, Zimmerhackl L. Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients. Pediatr Nephrol. 2011;26:663-73 pubmed publisher

Hull C, Brunton S. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis. Postgrad Med. 2010;122:1-6 pubmed

Rajalakshmi R, Kumari R, Thappa D. Acyclovir versus valacyclovir. Indian J Dermatol Venereol Leprol. 2010;76:439-44 pubmed publisher

Choong K, Walker N, Apel A, Whitby M. Aciclovir-resistant herpes keratitis. Clin Exp Ophthalmol. 2010;38:309-13 pubmed publisher

Vanpouille C, Lisco A, Margolis L. Acyclovir: a new use for an old drug. Curr Opin Infect Dis. 2009;22:583-7 pubmed publisher

Allen D, Dunn L. WITHDRAWN: Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2009;:CD001869 pubmed publisher

Hudson B, Powell C. Towards evidence based medicine for paediatricians. Does oral aciclovir improve clinical outcome in immunocompetent children with primary herpes simplex gingivostomatitis?. Arch Dis Child. 2009;94:165-7 pubmed publisher

Cortesi R, Esposito E. Acyclovir delivery systems. Expert Opin Drug Deliv. 2008;5:1217-30 pubmed

Nasser M, Fedorowicz Z, Khoshnevisan M, Shahiri Tabarestani M. Acyclovir for treating primary herpetic gingivostomatitis. Cochrane Database Syst Rev. 2008;:CD006700 pubmed publisher

Hatchette T, Tipples G, Peters G, Alsuwaidi A, Zhou J, Mailman T. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J. 2008;27:75-7 pubmed

Frobert E, Thouvenot D, Lina B, Morfin F. [Genotyping diagnosis of acyclovir resistant herpes simplex virus]. Pathol Biol (Paris). 2007;55:504-11 pubmed

Shelley B, Raniga S, Al Khabouri J. An unusual late complication of intracerebral haematoma in herpes encephalitis after successful acyclovir treatment. J Neurol Sci. 2007;252:177-80 pubmed

Montalbano M, Slapak Green G, Neff G. Fulminant hepatic failure from herpes simplex virus: post liver transplantation acyclovir therapy and literature review. Transplant Proc. 2005;37:4393-6 pubmed

Klassen T, Hartling L, Wiebe N, Belseck E. Acyclovir for treating varicella in otherwise healthy children and adolescents. Cochrane Database Syst Rev. 2005;:CD002980 pubmed

Harris D, Redhead J. Should acyclovir be prescribed for immunocompetent children presenting with chickenpox?. Arch Dis Child. 2005;90:648-50 pubmed

D Amico M, Fraticelli M, Limido A. [On the mailing list: use of acyclovir in patients on hemodialysis]. G Ital Nefrol. 2005;22:66-9 pubmed

Valencia I, Miles D, Melvin J, Khurana D, Kothare S, Hardison H, et al. Relapse of herpes encephalitis after acyclovir therapy: report of two new cases and review of the literature. Neuropediatrics. 2004;35:371-6 pubmed

Madigosky W, Meadows S, McCormack O. Clinical inquiries. Does acyclovir help herpes simplex virus cold sores if treatment is delayed?. J Fam Pract. 2004;53:923-4 pubmed

Allen D, Dunn L. Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2004;:CD001869 pubmed

Kelly D, Kroll J. Encephalitis--beyond aciclovir. Adv Exp Med Biol. 2004;549:177-83 pubmed

Klassen T, Belseck E, Wiebe N, Hartling L. Acyclovir for treating varicella in otherwise healthy children and adolescents. Cochrane Database Syst Rev. 2004;:CD002980 pubmed

Sheffield J, Hollier L, Hill J, Stuart G, Wendel G. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol. 2003;102:1396-403 pubmed

Tomori K, Isozumi K, Motohashi S, Komatsumoto S, Fukuuchi Y. [A young patient of acute encephalitis complicated with acyclovir encephalopathy without renal dysfunction]. Rinsho Shinkeigaku. 2003;43:470-6 pubmed

Chilukuri S, Rosen T. Management of acyclovir-resistant herpes simplex virus. Dermatol Clin. 2003;21:311-20 pubmed

Morfin F, Frobert E, Thouvenot D. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. Ann Biol Clin (Paris). 2003;61:33-40 pubmed

Sipe J, Dunn L. Aciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2001;:CD001869 pubmed

Sipe J, Dunn L. Aciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2001;:CD001869 pubmed

Leflore S, Anderson P, Fletcher C. A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections. Drug Saf. 2000;23:131-42 pubmed

Rubsam L, Davidson B, Shewach D. Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing. Cancer Res. 1998;58:3873-82 pubmed

Tong X, Engehausen D, Kaufman R, Agoulnik I, Contant C, Freund C, et al. Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. Anticancer Res. 1998;18:713-8 pubmed

Smiley M, Murray A. Aciclovir and its l-valyl ester, valaciclovir. Curr Probl Dermatol. 1996;24:209-18 pubmed

Wagstaff A, Faulds D, Goa K. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1994;47:153-205 pubmed

Ochiai H, Kumura K, Minamishima Y. Murine cytomegalovirus DNA polymerase: purification, characterization and role in the antiviral activity of acyclovir. Antiviral Res. 1992;17:1-16 pubmed